Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 16 GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway Authors Xiang J , Qin L , Zhong J, Xia N , Liang Y Received 12 June 2023 Accepted for publication 5 August 2023 Published 15 August 2023 Volume 2023:16 Pages 24332446 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Konstantinos Tziomalos Jie Xiang, 1 Liyan Qin, 2 Jinling Zhong, 3 Ning Xia, 2 Yuzhen Liang 3 1 Department of Clinical Nutrition, The First Affiliated Hospital of Guangxi Medical University, Nanning, Peoples Republic of China
Supports energy production, which can help improve both mental and physical vitality
Long-range electrostatic interactions were treated utilizing the particle mesh Ewald (PME) method with a cutoff distance of 1 nm
It is therefore possible to be B12 deficient despite having high B12 blood levels for example, if the vitamin cannot correctly bind to transport molecules (6)
Studies Linking Ozempic/GLP-1 to NAION Several recent studies have found a potential link between semaglutide (the active ingredient in Ozempic, Wegovy and Rybelsus) and non-arteritic anterior ischemic optic neuropathy (NAION), including: NAION Signs & Symptoms NAION signs and symptoms can potentially include: Sudden vision loss in one eye Painless loss of vision Monocular vision loss Visual field defects Dark or shadowy areas in vision Altitudinal field defect Loss of vision in lower half of visual field Loss of vision in upper half visual field Blind spot in center of field of vision (central scotoma) Loss of vision in the outer parts of the visual field Peripheral vision loss Pale optic nerve head Pallor of the optic disc Optic disc edema (optic disc swelling) Optic nerve swollen Optic atrophy Optic nerve fibers degenerate Decreased visual acuity Reduction sharpness of vision Blood vessel abnormalities Peripapillary hemorrhage (bleeding) Optic disc hemorrhage Decreased color vision Absence of inflammation of the eye Afferent pupillary defect (APD) / Marcus Gunn Pupil Other NAION symptoms or signs Procedures and tests used by ophthalmologists (or neuro-ophthalmologists) to diagnose NAION can include a comprehensive eye exam (including visual acuity, color vision testing, pupil examination for an afferent pupillary defect, and dilated funduscopic examination to view the optic nerve), visual field testing, optical coherence tomography (OCT) of the optic nerve head and retinal nerve fiber layer, fluorescein angiography to assess optic nerve blood flow and blood tests to rule out other conditions
